Elevated Neutrophil-to-Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma

被引:0
|
作者
Foerster, Yannick [1 ]
Mayer, Kristine [1 ]
Wasserer, Sophia [1 ]
Dechant, Marta [1 ]
Verkhoturova, Vitalina [1 ]
Heyer, Sarah [1 ]
Biedermann, Tilo [1 ]
Persa, Oana-Diana [1 ]
机构
[1] TUM Sch Med & Hlth, Dept Dermatol, Munich, Germany
来源
CANCER MEDICINE | 2025年 / 14卷 / 03期
关键词
checkpoint; immunotherapy; liver metastasis; melanoma; neutrophil-to-lymphocyte ratio; NLR; OPEN-LABEL; NIVOLUMAB; CHEMOTHERAPY; IPILIMUMAB;
D O I
10.1002/cam4.70631
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and ObjectivesImmune checkpoint inhibition (ICI) has revolutionized treatment for metastasized melanoma, but many patients remain unresponsive. Concerning potential adverse events, reliable biomarkers to predict ICI response are needed. In this context, neutrophil-to-lymphocyte ratio (NLR) and derived NLR (dNLR) have emerged. Liver metastases also limit ICI efficacy, correlating with diminished overall survival (OS) and progression-free survival (PFS) and may siphon activated T cells from the systemic circulation, creating an 'immune desert state'. We evaluated the predictive role of NLR and dNLR for ICI response and the impact of liver metastases on systemic immunity and treatment efficacy.Patients and MethodsIn this single-center retrospective study, we included 141 stage IV melanoma patients undergoing ICI. NLR and dNLR were calculated from absolute neutrophil count, absolute lymphocyte count, and white blood cell count.ResultsElevated NLR and dNLR were associated with poor response to ICI and inferior PFS. Patients with liver metastases exhibited higher NLR and dNLR levels and showed diminished response to ICI.ConclusionsElevated baseline NLR and dNLR predict poor response to ICI and PFS in stage IV melanoma. Liver metastases are negative predictors for ICI response, with associated higher NLR and dNLR levels potentially contributing to therapy resistance.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy
    Kartolo, Adi
    Holstead, Ryan
    Khalid, Sidra
    Emack, Jeffrey
    Hopman, Wilma
    Robinson, Andrew
    Baetz, Tara
    IMMUNOTHERAPY, 2020, 12 (11) : 785 - 798
  • [22] Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases
    Verter, Eden
    Berger, Yael
    Perl, Gali
    Peretz, Idit
    Tovar, Ana
    Morgenstern, Sara
    Brenner, Baruch
    Benchimol, Daniel
    Kashtan, Hanoch
    Sadot, Eran
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4320 - 4329
  • [23] The neutrophil-to-lymphocyte ratio as a predictor for recurrence of colorectal liver metastases following radiofrequency ablation
    Chang, Zhihui
    Zheng, Jiahe
    Ma, Yujia
    Zhao, Jian
    Wang, Chuanzhuo
    Liu, Zhaoyu
    MEDICAL ONCOLOGY, 2014, 31 (03)
  • [24] Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases
    Eden Verter
    Yael Berger
    Gali Perl
    Idit Peretz
    Ana Tovar
    Sara Morgenstern
    Baruch Brenner
    Daniel Benchimol
    Hanoch Kashtan
    Eran Sadot
    Annals of Surgical Oncology, 2021, 28 : 4320 - 4329
  • [25] Elevated neutrophil-to-lymphocyte ratio is associated with poor outcomes in patients with chronic thromboembolic pulmonary hypertension
    Ozturk, Nilufer Aylin Acet
    Polatkan, Seyda Gunay
    Guclu, Ozge Aydin
    Terzi, Orkun Eray
    Ozpehlivan, Arzu
    Bicer, Murat
    Bayram, Ahmet Sami
    Pehlivan, Yavuz
    Coskun, Belkis Nihan
    Yesilbursa, Dilek
    Gullulu, Sumeyye
    Coskun, Funda
    EURASIAN JOURNAL OF PULMONOLOGY, 2025, 27 (01) : 43 - 49
  • [26] Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
    Jiang, Chang
    Hu, Wan-Ming
    Liao, Fang-Xin
    Yang, Qiong
    Chen, Ping
    Rong, Yu-Ming
    Guo, Gui-Fang
    Yin, Chen-Xi
    Zhang, Bei
    He, Wen-Zhuo
    Xia, Liang-Ping
    ONCOTARGETS AND THERAPY, 2016, 9 : 877 - 883
  • [27] Elevated blood neutrophil-to-lymphocyte ratio is associated with poor clinical outcome in patients with synovial sarcoma
    Zhou, L.
    Chan, J. Y.
    Tan, G. F. M.
    Lim, C. L. W.
    Goh, W. L.
    Sathiyamoorthy, S.
    Sittampalam, K.
    Teh, J.
    Chin, F.
    Tan, M. H.
    Soo, K. C.
    Teo, M.
    Farid, M.
    Quek, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer
    Kim, Jung Hyun
    Lee, Jae-Hoon
    Lee, Hye Sun
    Shin, Su-Jin
    Park, Eun Jung
    Cho, Eun-Suk
    Baik, Seung Hyuk
    Lee, Kang Young
    Kang, Jeonghyun
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 4457 - 4466
  • [29] Neutrophil to Lymphocyte Ratio (NLR) as an Independent Prognostic Measure in Patients Receiving Targeted Therapy or Immunotherapy for Stage IV Melanoma
    Blackley, E.
    Lim, L. E.
    Moore, M.
    Voskoboynik, M.
    McLean, C.
    Haydon, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 50 - 50
  • [30] Neutrophil to Lymphocyte Ratio (NLR) as an independent prognostic measure in patients receiving targeted therapy or immunotherapy for stage IV melanoma
    Blackley, E.
    Lim, L. E.
    Moore, M.
    Voskoboynik, M.
    McLean, C.
    Haydon, A.
    ANNALS OF ONCOLOGY, 2017, 28